Biotech stocks in Korea surged after the UK approved a gene editing therapy developed by Vertex Pharmaceuticals and Crispr Therapeutics to treat blood disorders.
ToolGen, a Korean gene therapy developer, is trading strong in the Kosdaq market on Friday, as the British authorities granted the world's first approval for gene-editing treatment.
The 2020 Nobel Prize in Chemistry went to Emmanuelle Charpentier, a French microbiologist of the Max Planck Unit for the Science of Pathogens, Berlin, and Jennifer A. Doudna, an American biochemist at the University of...
Korea JoongAng Daily Sitemap
